| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
Departments of
*
Biochemistry,
Microbiology and Immunology, and
Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461;
The Jackson Laboratory, Bar Harbor, ME 04609;
¶ Department of Molecular and Cell Biology, University of California, Berkeley, CA; and
||
The La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
The mouse H13 minor histocompatibility (H) Ag, originally detected as a barrier to allograft transplants, is remarkable in that rejection is a consequence of an extremely subtle interchange, P4Val/Ile, in a nonamer H2-Db-bound peptide. Moreover, H13 peptides lack the canonical P5Asn central anchor residue normally considered important for forming a peptide/MHC complex. To understand how these noncanonical peptide pMHC complexes form physiologically active TCR ligands, crystal structures of allelic H13 pDb complexes and a P5Asn anchored pDb analog were solved to high resolution. The structures show that the basis of TCRs to distinguish self from nonself H13 peptides is their ability to distinguish a single solvent-exposed methyl group. In addition, the structures demonstrate that there is no need for H13 peptides to derive any stabilization from interactions within the central C pocket to generate fully functional pMHC complexes. These results provide a structural explanation for a classical non-MHC-encoded H Ag, and they call into question the requirement for contact between anchor residues and the major MHC binding pockets in vaccine design.
This article has been cited by other articles:
|
|
 |
|
  T. Kanaseki and N. Shastri Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing Regulates Quality of Processed Peptides Presented by MHC Class I Molecules J. Immunol., November 1, 2008; 181(9): 6275 - 6282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mitaksov and D. H. Fremont Structural Definition of the H-2Kd Peptide-binding Motif J. Biol. Chem., April 14, 2006; 281(15): 10618 - 10625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takaki, S. M. Lieberman, T. M. Holl, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo Requirement for Both H-2Db and H-2Kd for the Induction of Diabetes by the Promiscuous CD8+ T Cell Clonotype AI4 J. Immunol., August 15, 2004; 173(4): 2530 - 2541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Santori, K. Holmberg, D. Ostrov, N. R. J. Gascoigne, and S. Vukmanovic Distinct Footprints of TCR Engagement with Highly Homologous Ligands J. Immunol., June 15, 2004; 172(12): 7466 - 7475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. H. G. Kessels, K. E. de Visser, F. H. Tirion, M. Coccoris, A. M. Kruisbeek, and T. N. M. Schumacher The Impact of Self-Tolerance on the Polyclonal CD8+ T Cell Repertoire J. Immunol., February 15, 2004; 172(4): 2324 - 2331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yadav, Y. Yoshimura, A. Boesteanu, G. J. Christianson, W. U. Ajayi, R. Shashidharamurthy, A. K. Stanic, D. C. Roopenian, and S. Joyce The H4b Minor Histocompatibility Antigen Is Caused by a Combination of Genetically Determined and Posttranslational Modifications J. Immunol., May 15, 2003; 170(10): 5133 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mommaas, J. Kamp, J.-W. Drijfhout, N. Beekman, F. Ossendorp, P. van Veelen, J. den Haan, E. Goulmy, and T. Mutis Identification of a Novel HLA-B60-Restricted T Cell Epitope of the Minor Histocompatibility Antigen HA-1 Locus J. Immunol., September 15, 2002; 169(6): 3131 - 3136. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
